The choice of antibiotic for community-acquired pneumonia – the results of a survey of doctors and an analysis of real outpatient practice

Community-acquired pneumonia (CAP) remains an urgent problem in the structure of infectious diseases worldwide including the Russian Federation. According to medical statistics the incidence rate of CAP increased by 19.1 % by December 2018 as compared to year 2017. The authors addressed the problem...

Full description

Bibliographic Details
Main Authors: V. G. Deriushkin, A. P. Ternavskii, E. A. Ulyanova, S. V. Gatsura
Format: Article
Language:Russian
Published: Izdatelstvo OKI 2020-04-01
Series:Качественная клиническая практика
Subjects:
Online Access:https://www.clinvest.ru/jour/article/view/479
_version_ 1827318063193653248
author V. G. Deriushkin
A. P. Ternavskii
E. A. Ulyanova
S. V. Gatsura
author_facet V. G. Deriushkin
A. P. Ternavskii
E. A. Ulyanova
S. V. Gatsura
author_sort V. G. Deriushkin
collection DOAJ
description Community-acquired pneumonia (CAP) remains an urgent problem in the structure of infectious diseases worldwide including the Russian Federation. According to medical statistics the incidence rate of CAP increased by 19.1 % by December 2018 as compared to year 2017. The authors addressed the problem of rational choice of antimicrobial agents (AMAs) for outpatient treatment of this disease. The aim was to assess structure and rationality of choice of AMAs for outpatient treatment of CAP by primary care physicians in municipal outpatient clinics in Moscow. A two-stage single-center pharmacoepidemic study was conducted. The survey involved 45 primary care physicians with average age 48.5 ± 13.2 years and medical experience 22.7 ± 13.6 years. Relevant information was also copied out from 650 ambulatory records of patients receiving AMs for CAP. According to the results of our survey the leaders of the respondents’ preferences are beta-lactam antibiotics — amoxicillin/clavulanate (49.0 %) followed by amoxicillin (25.5 %) and cephalosporins (15.7 %). Analysis of real clinical practice brings different picture: cephalosporins become comparable to amoxicillin/clavulanate in terms of frequency of administration, The latter significantly loses popularity, as does amoxicillin as monotherapy These data match with similar survey of 233 Moscow primary care physicians conducted earlier in 2013-2014 by one of the authors where amoxicillin/clavulanate accounted for 43.6 % of total AMAs recommendations. Thus, the initial choice of AMAs for outpatient treatment of CAP in most cases does not comply with current clinical guidelines. Physicians tend to start initial outpatient management of CAP with second-line AMAs (amoxicillin/clavulanate, cephalosporins, less commonly fluoroquinolones), underestimating macrolides and almost neglecting doxycycline. These circumstances result in unwarranted increase in drug load on the patient, decrease in safety of treatment and ineffectiveness of antimicrobial therapy in case if CAP is caused by atypical pathogens.
first_indexed 2024-04-24T23:51:08Z
format Article
id doaj.art-b0b04c9640c04bca8ccc38473acee695
institution Directory Open Access Journal
issn 2588-0519
2618-8473
language Russian
last_indexed 2024-04-24T23:51:08Z
publishDate 2020-04-01
publisher Izdatelstvo OKI
record_format Article
series Качественная клиническая практика
spelling doaj.art-b0b04c9640c04bca8ccc38473acee6952024-03-14T18:09:08ZrusIzdatelstvo OKIКачественная клиническая практика2588-05192618-84732020-04-01045054463The choice of antibiotic for community-acquired pneumonia – the results of a survey of doctors and an analysis of real outpatient practiceV. G. Deriushkin0A. P. Ternavskii1E. A. Ulyanova2S. V. Gatsura3ФГБОУ ВО «Московский государственный медико-стоматологический университет им. А.И. Евдокимова» Минздрава РоссииГБУЗ «ГБУЗ ГП №175 ДЗМ»ФГБОУ ВО «Московский государственный медико-стоматологический университет им. А.И. Евдокимова» Минздрава РоссииФГБОУ ВО «Московский государственный медико-стоматологический университет им. А.И. Евдокимова» Минздрава РоссииCommunity-acquired pneumonia (CAP) remains an urgent problem in the structure of infectious diseases worldwide including the Russian Federation. According to medical statistics the incidence rate of CAP increased by 19.1 % by December 2018 as compared to year 2017. The authors addressed the problem of rational choice of antimicrobial agents (AMAs) for outpatient treatment of this disease. The aim was to assess structure and rationality of choice of AMAs for outpatient treatment of CAP by primary care physicians in municipal outpatient clinics in Moscow. A two-stage single-center pharmacoepidemic study was conducted. The survey involved 45 primary care physicians with average age 48.5 ± 13.2 years and medical experience 22.7 ± 13.6 years. Relevant information was also copied out from 650 ambulatory records of patients receiving AMs for CAP. According to the results of our survey the leaders of the respondents’ preferences are beta-lactam antibiotics — amoxicillin/clavulanate (49.0 %) followed by amoxicillin (25.5 %) and cephalosporins (15.7 %). Analysis of real clinical practice brings different picture: cephalosporins become comparable to amoxicillin/clavulanate in terms of frequency of administration, The latter significantly loses popularity, as does amoxicillin as monotherapy These data match with similar survey of 233 Moscow primary care physicians conducted earlier in 2013-2014 by one of the authors where amoxicillin/clavulanate accounted for 43.6 % of total AMAs recommendations. Thus, the initial choice of AMAs for outpatient treatment of CAP in most cases does not comply with current clinical guidelines. Physicians tend to start initial outpatient management of CAP with second-line AMAs (amoxicillin/clavulanate, cephalosporins, less commonly fluoroquinolones), underestimating macrolides and almost neglecting doxycycline. These circumstances result in unwarranted increase in drug load on the patient, decrease in safety of treatment and ineffectiveness of antimicrobial therapy in case if CAP is caused by atypical pathogens.https://www.clinvest.ru/jour/article/view/479внебольничная пневмониярациональная фармакотерапияантимикробный препаратфармако-эпидемиологияобщая врачебная практика
spellingShingle V. G. Deriushkin
A. P. Ternavskii
E. A. Ulyanova
S. V. Gatsura
The choice of antibiotic for community-acquired pneumonia – the results of a survey of doctors and an analysis of real outpatient practice
Качественная клиническая практика
внебольничная пневмония
рациональная фармакотерапия
антимикробный препарат
фармако-эпидемиология
общая врачебная практика
title The choice of antibiotic for community-acquired pneumonia – the results of a survey of doctors and an analysis of real outpatient practice
title_full The choice of antibiotic for community-acquired pneumonia – the results of a survey of doctors and an analysis of real outpatient practice
title_fullStr The choice of antibiotic for community-acquired pneumonia – the results of a survey of doctors and an analysis of real outpatient practice
title_full_unstemmed The choice of antibiotic for community-acquired pneumonia – the results of a survey of doctors and an analysis of real outpatient practice
title_short The choice of antibiotic for community-acquired pneumonia – the results of a survey of doctors and an analysis of real outpatient practice
title_sort choice of antibiotic for community acquired pneumonia the results of a survey of doctors and an analysis of real outpatient practice
topic внебольничная пневмония
рациональная фармакотерапия
антимикробный препарат
фармако-эпидемиология
общая врачебная практика
url https://www.clinvest.ru/jour/article/view/479
work_keys_str_mv AT vgderiushkin thechoiceofantibioticforcommunityacquiredpneumoniatheresultsofasurveyofdoctorsandananalysisofrealoutpatientpractice
AT apternavskii thechoiceofantibioticforcommunityacquiredpneumoniatheresultsofasurveyofdoctorsandananalysisofrealoutpatientpractice
AT eaulyanova thechoiceofantibioticforcommunityacquiredpneumoniatheresultsofasurveyofdoctorsandananalysisofrealoutpatientpractice
AT svgatsura thechoiceofantibioticforcommunityacquiredpneumoniatheresultsofasurveyofdoctorsandananalysisofrealoutpatientpractice
AT vgderiushkin choiceofantibioticforcommunityacquiredpneumoniatheresultsofasurveyofdoctorsandananalysisofrealoutpatientpractice
AT apternavskii choiceofantibioticforcommunityacquiredpneumoniatheresultsofasurveyofdoctorsandananalysisofrealoutpatientpractice
AT eaulyanova choiceofantibioticforcommunityacquiredpneumoniatheresultsofasurveyofdoctorsandananalysisofrealoutpatientpractice
AT svgatsura choiceofantibioticforcommunityacquiredpneumoniatheresultsofasurveyofdoctorsandananalysisofrealoutpatientpractice